Literature DB >> 21691919

Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome.

Peter Kies1, Matthias Paul, Joachim Gerss, Lars Stegger, Gerold Mönnig, Otmar Schober, Thomas Wichter, Michael Schäfers, Eric Schulze-Bahr.   

Abstract

PURPOSE: Increased sympathetic activation is a key modifier for arrhythmogenesis in patients with long QT syndrome (LQTS), a congenital channelopathy. Therefore, we investigated cardiac sympathetic function using 123I-metaiodobenzylguanidine (MIBG) single photon emission computed tomography (SPECT) in a cohort of symptomatic LQTS patients and correlated these findings with the underlying genotype.
METHODS: [123I]MIBG SPECT was performed in 28 LQTS patients. Among these, 18 patients (64%) had a previous syncope and 10 patients (36%) survived sudden cardiac arrest. Patients were characterized in terms of genetic subtypes and QTc interval on surface ECGs. SPECT images were analysed for regional [123I]MIBG uptake in a 33-segment bullseye scheme and compared to those obtained from 10 age-matched healthy control subjects (43±12 years).
RESULTS: An abnormal 123I-MIBG scan was found in 17 of 28 LQTS patients (61%) with a tracer reduction mainly located in the anteroseptal segments of the left ventricle. This finding was independent of the genetic LQTS subtype. In addition, no differences were found between LQTS patients with a QTc>500 ms vs <500 ms or those suffering from syncope vs VF (p>0.05).
CONCLUSION: A distinct regional pattern of impaired cardiac sympathetic function was identified in the majority of symptomatic LQTS patients. This innervation defect was independent of the underlying genotype and clinical disease expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691919     DOI: 10.1007/s00259-011-1852-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  32 in total

1.  Clinical implications for affected parents and siblings of probands with long-QT syndrome.

Authors:  J Kimbrough; A J Moss; W Zareba; J L Robinson; W J Hall; J Benhorin; E H Locati; A Medina; C Napolitano; S Priori; P J Schwartz; K Timothy; J A Towbin; G M Vincent; L Zhang
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

2.  Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members.

Authors:  E S Kaufman; S G Priori; C Napolitano; P J Schwartz; S Iyengar; R C Elston; A H Schnell; E Z Gorodeski; G Rammohan; N O Bahhur; D Connuck; L Verrilli; D S Rosenbaum; A M Brown
Journal:  J Cardiovasc Electrophysiol       Date:  2001-04

3.  Cardiac 123I-MIBG uptake in idiopathic ventricular tachycardia and fibrillation.

Authors:  M Schäfers; T Wichter; H Lerch; P Matheja; T Kuwert; K Schäfers; M Borggrefe; G Breithardt; O Schober
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

4.  Idiopathic long QT syndrome: progress and questions.

Authors:  P J Schwartz
Journal:  Am Heart J       Date:  1985-02       Impact factor: 4.749

5.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

6.  Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome.

Authors:  H Yamanari; K Nakayama; H Morita; K Miyazi; K Fukushima; H Matsubara; T Emori; T Ohe
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

7.  Effects of beta-blocker therapy on ventricular repolarization documented by 24-h electrocardiography in patients with type 1 long-QT syndrome.

Authors:  Matti Viitasalo; Lasse Oikarinen; Heikki Swan; Heikki Väänänen; Jere Järvenpää; Harri Hietanen; Jouko Karjalainen; Lauri Toivonen
Journal:  J Am Coll Cardiol       Date:  2006-07-25       Impact factor: 24.094

8.  Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia.

Authors:  M C Sanguinetti; M E Curran; P S Spector; M T Keating
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

9.  Long QT syndrome in adults.

Authors:  Andrew J Sauer; Arthur J Moss; Scott McNitt; Derick R Peterson; Wojciech Zareba; Jennifer L Robinson; Ming Qi; Ilan Goldenberg; Jenny B Hobbs; Michael J Ackerman; Jesaia Benhorin; W Jackson Hall; Elizabeth S Kaufman; Emanuela H Locati; Carlo Napolitano; Silvia G Priori; Peter J Schwartz; Jeffrey A Towbin; G Michael Vincent; Li Zhang
Journal:  J Am Coll Cardiol       Date:  2007-01-04       Impact factor: 24.094

10.  Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

Authors:  Silvia G Priori; Carlo Napolitano; Peter J Schwartz; Massimiliano Grillo; Raffaella Bloise; Elena Ronchetti; Cinzia Moncalvo; Chiara Tulipani; Alessia Veia; Georgia Bottelli; Janni Nastoli
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

View more
  2 in total

Review 1.  The potential role of iodine-123 metaiodobenzylguanidine imaging for identifying sustained ventricular tachycardia in patients with cardiomyopathy.

Authors:  Thomas Klein; Vasken Dilsizian; Qi Cao; Wengen Chen; Timm-Michael Dickfeld
Journal:  Curr Cardiol Rep       Date:  2013-05       Impact factor: 2.931

2.  Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGs.

Authors:  Alexander Samol; Mehmet Gönes; Sven Zumhagen; Hans-Jürgen Bruns; Matthias Paul; Christian Vahlhaus; Johannes Waltenberger; Eric Schulze-Bahr; Lars Eckardt; Gerold Mönnig
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.